• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURLESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURLESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583); Folded (2630)
Patient Problem No Information (3190)
Event Date 06/25/2017
Event Type  Injury  
Manufacturer Narrative
The physician has indicated as per medical judgment that a possible over-sizing of the perceval valve may have contributed to this event.Device not explanted.
 
Event Description
On july 4th 2017 the manufacturer was notified of the following event: on (b)(6) 2017 a perceval size 23 was implanted.Two (2) days from the implant on (b)(6) a leak was observed and the inflow stent appeared to be folded by echo.The physician performed a dilation with a balloon in the cath lab.This procedure gave a positive outcome.Ten (10) days post implant a valve in valve procedure was then performed, a sapien size 23 was implanted.The patient is doing well.
 
Manufacturer Narrative
The complete manufacturing and material records for the perceval heart valve and nitinol stent component, model #icv1209 , s/n # (b)(4) were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) percevalheart valve at the time of manufacture and release.As the device was not explanted no further investigation is possible at this time.The physician has indicated as per medical judgment that a possible over-sizing of the perceval valve may have contributed to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURLESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA  V5J5M1
Manufacturer (Section G)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key6760887
MDR Text Key81627283
Report Number3004478276-2017-00140
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)200727
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date07/27/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-